Tika Ram Lamichhane
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tika Ram Lamichhane has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Madhav Prasad Ghimire
Tribhuvan University
9 shared publications Kamal Khanal
Tribhuvan University
8 shared publicationsMadhav Prasad Ghimire
Tribhuvan University
7 shared publicationsMohan Bahadur Kshetri
Tribhuvan University
7 shared publicationsRajesh Maharjan
Central Department of Physics Tribhuvan University Kathmandu Nepal
7 shared publicationsArjun Acharya
Central Department of Physics Tribhuvan University Kathmandu Nepal
5 shared publications
Latest Publications
- 30 September 2026
- Published by Taylor & Francis in Molecular Physics
Physicochemical properties of syringic acid-adsorbed XZn 11 O 12 (X = Zn, Ti, Ni, Zr) nanocages and binding interactions with aureusimine biosynthetic cluster reductase domain
1. Syringic acid (SA), a phenolic compound occurring naturally in various plant sources, displays numerous pharmacological effects, including antimicrobial, anticancer, anti-inflammatory, antidiabe...
- 30 September 2026
- Published by Taylor & Francis in Molecular Physics
Physicochemical properties of syringic acid-adsorbed XZn 11 O 12 (X = Zn, Ti, Ni, Zr) nanocages and binding interactions with aureusimine biosynthetic cluster reductase domain
1. Syringic acid (SA), a phenolic compound occurring naturally in various plant sources, displays numerous pharmacological effects, including antimicrobial, anticancer, anti-inflammatory, antidiabe...
- Open Access
- 22 July 2026
- Published by Elsevier in Next Materials
- Vol. 13
A comprehensive in silico study of caffeic acid-adsorbed XTi2O6H2 (X = Ti, Pt, Zr, Zn) nanostructures and inhibition potential against dihydropteroate synthase
- 22 July 2026
- Published by Elsevier in Next Materials
- Vol. 13
Open AccessA comprehensive in silico study of caffeic acid-adsorbed XTi2O6H2 (X = Ti, Pt, Zr, Zn) nanostructures and inhibition potential against dihydropteroate synthase
- Open Access
- 4 March 2026
- Published by Wiley in ChemistryOpen
- Vol. 15 (3)
Quantum Chemical Properties of Fluorouracil/XZn 11 O 12 (X = Zn, Cu, Fe, Ni) Nanocomplexes and Interactions with Human Serum Albumin
This research focused on structural, electronic, and interaction properties of fluorouracil (5‐FU) adsorbed on transition metal (TM)‐doped ZnO nanoclusters (XZn 11 O 12 , where X = Zn, Cu, Fe, Ni) using density functional theory (DFT) at the B3LYP/LANL2DZ level of calculations in the gas phase. Among the studied nanocomplexes, 5‐FU@NiZn 11 O 12 exhibited the highest dipole moment (8.08 D), indicating strong polarization and potential surface reactivity though it has a less negative adsorption energy (−20.97 kcal/mol) compared to 5‐FU@FeZn 11 O 12 (−35.51 kcal/mol) and 5‐FU@CuZn 11 O 12 (−28.69 kcal/mol). TM doping significantly reduced the highest occupied molecular orbital–lowest unoccupied molecular orbital gap, with 5‐FU@NiZn 11 O 12 showing the lowest value (2.44 eV), followed by 5‐FU@FeZn 11 O 12 (2.53 eV) and 5‐FU@CuZn 11 O 12 (3.18 eV), suggesting enhanced charge transfer and chemical reactivity. The results from molecular electrostatic potential, quantum theory of atoms in molecules, and non–covalent interaction/reduced density gradient analyses were also in favor of Ni‐doped ZnO nanocomplex. Based on the DFT results, 5FU@NiZn 11 O 12 was selected to analyze its interactions with human serum albumin (HSA). From molecular docking of 5‐FU@NiZn 11 O 12 , binding energy (−5.36 kcal/mol) and inhibition constant (117.15 μM) exhibited stronger interactions with HSA, so that it acts as a potential candidate of drug delivery system for anticancer therapy. However, these predictive insights require further experimental validation.
- 4 March 2026
- Published by Wiley in ChemistryOpen
- Vol. 15 (3)
Open AccessQuantum Chemical Properties of Fluorouracil/XZn 11 O 12 (X = Zn, Cu, Fe, Ni) Nanocomplexes and Interactions with Human Serum Albumin
This research focused on structural, electronic, and interaction properties of fluorouracil (5‐FU) adsorbed on transition metal (TM)‐doped ZnO nanoclusters (XZn 11 O 12 , where X = Zn, Cu, Fe, Ni) using density functional theory (DFT) at the B3LYP/LANL2DZ level of calculations in the gas phase. Among the studied nanocomplexes, 5‐FU@NiZn 11 O 12 exhibited the highest dipole moment (8.08 D), indicating strong polarization and potential surface reactivity though it has a less negative adsorption energy (−20.97 kcal/mol) compared to 5‐FU@FeZn 11 O 12 (−35.51 kcal/mol) and 5‐FU@CuZn 11 O 12 (−28.69 kcal/mol). TM doping significantly reduced the highest occupied molecular orbital–lowest unoccupied molecular orbital gap, with 5‐FU@NiZn 11 O 12 showing the lowest value (2.44 eV), followed by 5‐FU@FeZn 11 O 12 (2.53 eV) and 5‐FU@CuZn 11 O 12 (3.18 eV), suggesting enhanced charge transfer and chemical reactivity. The results from molecular electrostatic potential, quantum theory of atoms in molecules, and non–covalent interaction/reduced density gradient analyses were also in favor of Ni‐doped ZnO nanocomplex. Based on the DFT results, 5FU@NiZn 11 O 12 was selected to analyze its interactions with human serum albumin (HSA). From molecular docking of 5‐FU@NiZn 11 O 12 , binding energy (−5.36 kcal/mol) and inhibition constant (117.15 μM) exhibited stronger interactions with HSA, so that it acts as a potential candidate of drug delivery system for anticancer therapy. However, these predictive insights require further experimental validation.
- Open Access
- 1 March 2026
- Vol. 15 (3) , e202500535
Quantum Chemical Properties of Fluorouracil/XZn11O12 (X = Zn, Cu, Fe, Ni) Nanocomplexes and Interactions with Human Serum Albumin.
This research focused on structural, electronic, and interaction properties of fluorouracil (5-FU) adsorbed on transition metal (TM)-doped ZnO nanoclusters (XZn11O12, where X = Zn, Cu, Fe, Ni) using density functional theory (DFT) at the B3LYP/LANL2DZ level of calculations in the gas phase. Among the studied nanocomplexes, 5-FU@NiZn11O12 exhibited the highest dipole moment (8.08 D), indicating strong polarization and potential surface reactivity though it has a less negative adsorption energy (-20.97 kcal/mol) compared to 5-FU@FeZn11O12 (-35.51 kcal/mol) and 5-FU@CuZn11O12 (-28.69 kcal/mol). TM doping significantly reduced the highest occupied molecular orbital-lowest unoccupied molecular orbital gap, with 5-FU@NiZn11O12 showing the lowest value (2.44 eV), followed by 5-FU@FeZn11O12 (2.53 eV) and 5-FU@CuZn11O12 (3.18 eV), suggesting enhanced charge transfer and chemical reactivity. The results from molecular electrostatic potential, quantum theory of atoms in molecules, and non-covalent interaction/reduced density gradient analyses were also in favor of Ni-doped ZnO nanocomplex. Based on the DFT results, 5FU@NiZn11O12 was selected to analyze its interactions with human serum albumin (HSA). From molecular docking of 5-FU@NiZn11O12, binding energy (-5.36 kcal/mol) and inhibition constant (117.15 μM) exhibited stronger interactions with HSA, so that it acts as a potential candidate of drug delivery system for anticancer therapy. However, these predictive insights require further experimental validation.
- 1 March 2026
- Vol. 15 (3) , e202500535
Open AccessQuantum Chemical Properties of Fluorouracil/XZn11O12 (X = Zn, Cu, Fe, Ni) Nanocomplexes and Interactions with Human Serum Albumin.
This research focused on structural, electronic, and interaction properties of fluorouracil (5-FU) adsorbed on transition metal (TM)-doped ZnO nanoclusters (XZn11O12, where X = Zn, Cu, Fe, Ni) using density functional theory (DFT) at the B3LYP/LANL2DZ level of calculations in the gas phase. Among the studied nanocomplexes, 5-FU@NiZn11O12 exhibited the highest dipole moment (8.08 D), indicating strong polarization and potential surface reactivity though it has a less negative adsorption energy (-20.97 kcal/mol) compared to 5-FU@FeZn11O12 (-35.51 kcal/mol) and 5-FU@CuZn11O12 (-28.69 kcal/mol). TM doping significantly reduced the highest occupied molecular orbital-lowest unoccupied molecular orbital gap, with 5-FU@NiZn11O12 showing the lowest value (2.44 eV), followed by 5-FU@FeZn11O12 (2.53 eV) and 5-FU@CuZn11O12 (3.18 eV), suggesting enhanced charge transfer and chemical reactivity. The results from molecular electrostatic potential, quantum theory of atoms in molecules, and non-covalent interaction/reduced density gradient analyses were also in favor of Ni-doped ZnO nanocomplex. Based on the DFT results, 5FU@NiZn11O12 was selected to analyze its interactions with human serum albumin (HSA). From molecular docking of 5-FU@NiZn11O12, binding energy (-5.36 kcal/mol) and inhibition constant (117.15 μM) exhibited stronger interactions with HSA, so that it acts as a potential candidate of drug delivery system for anticancer therapy. However, these predictive insights require further experimental validation.
- Open Access
- 6 February 2026
- Published by Elsevier in Journal of Radiation Research and Applied Sciences
- Vol. 19 (1)
In silico investigation of Bi2O3 impact on the radiation and ion shielding properties of K2O–ZnO–V2O5–B2O3 glass system
- 6 February 2026
- Published by Elsevier in Journal of Radiation Research and Applied Sciences
- Vol. 19 (1)
Open AccessIn silico investigation of Bi2O3 impact on the radiation and ion shielding properties of K2O–ZnO–V2O5–B2O3 glass system
- 5 January 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (1)
In Silico Study of Luteolin and Eriodictyol as Xanthine Oxidase Inhibitors: An Integrated Approach Using Virtual Screening, DFT, Molecular Docking, MD Simulations, and ADMET Analysis
Xanthine oxidase (XO), a key enzyme in uric acid production, is a recognized therapeutic target for hyperuricemia. This study focused on an integrated in silico approach to find XO inhibitors from the selected natural compounds. Initially, eriodictyol and luteolin were identified as potential ligands based on their binding scores in virtual screening. Quantum mechanical calculations, including HOMO–LUMO energy gaps (eriodictyol: 4.62 eV and luteolin: 4.14 eV), electronic spectra, molecular electrostatic potential, Mulliken atomic charges, and density of states, suggested both the ligands have favorable electronic characteristics for interaction with the target macromolecule. Molecular docking calculations with XO demonstrated that luteolin exhibited a more favorable binding energy (−8.24 kcal/mol) compared to eriodictyol (‐8.04 kcal/mol), the reference drug allopurinol (‐5.94 kcal/mol), and XO substrate xanthine (‐5.79 kcal/mol). Further, the MM‐PBSA calculation also supported the stronger binding efficacy of luteolin (‐20.8 kcal/mol) compared to eriodictyol (−13.5 kcal/mol). Molecular dynamics simulations of both ligands with XO showed enhanced stability as supported by RMSD, RMSF, Rg, and SASA results. ADMET predictions recommended favorable pharmacokinetic and toxicity profiles for both the ligands. This computational study identifies eriodictyol and luteolin as promising XO inhibitors, with luteolin being more effective candidate.
- 5 January 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (1)
In Silico Study of Luteolin and Eriodictyol as Xanthine Oxidase Inhibitors: An Integrated Approach Using Virtual Screening, DFT, Molecular Docking, MD Simulations, and ADMET Analysis
Xanthine oxidase (XO), a key enzyme in uric acid production, is a recognized therapeutic target for hyperuricemia. This study focused on an integrated in silico approach to find XO inhibitors from the selected natural compounds. Initially, eriodictyol and luteolin were identified as potential ligands based on their binding scores in virtual screening. Quantum mechanical calculations, including HOMO–LUMO energy gaps (eriodictyol: 4.62 eV and luteolin: 4.14 eV), electronic spectra, molecular electrostatic potential, Mulliken atomic charges, and density of states, suggested both the ligands have favorable electronic characteristics for interaction with the target macromolecule. Molecular docking calculations with XO demonstrated that luteolin exhibited a more favorable binding energy (−8.24 kcal/mol) compared to eriodictyol (‐8.04 kcal/mol), the reference drug allopurinol (‐5.94 kcal/mol), and XO substrate xanthine (‐5.79 kcal/mol). Further, the MM‐PBSA calculation also supported the stronger binding efficacy of luteolin (‐20.8 kcal/mol) compared to eriodictyol (−13.5 kcal/mol). Molecular dynamics simulations of both ligands with XO showed enhanced stability as supported by RMSD, RMSF, Rg, and SASA results. ADMET predictions recommended favorable pharmacokinetic and toxicity profiles for both the ligands. This computational study identifies eriodictyol and luteolin as promising XO inhibitors, with luteolin being more effective candidate.
- Open Access
- 1 November 2025
- Published by IOP Publishing in Materials Research Express
- Vol. 12 (11) , 115001
In silico study on structural, electronic, and adsorption properties of cisplatin/(TiO 2 ) n (n = 2–5) nanoclusters and interactions with hen egg white lysozyme
This study explored the structural, adsorption, and electronic properties of titania nanostructures loaded with cisplatin (cis) using density functional theory (DFT) at the level of B3LYP/LANL2DZ functional in gas phase, and examined the binding potential of the cis-(TiO 2 ) n (n = 2–5) nanoclusters (NCs) with hen egg white lysozyme (HEWL) via molecular docking. Our results revealed that cisplatin adsorption on (TiO 2 ) n NCs yielded adsorption energies of −56.97, −53.84, −48.40, and −39.23 kcal mol −1 for cis-(TiO 2 ) 2 , cis-(TiO 2 ) 3 , cis-(TiO 2 ) 4 , and cis-(TiO 2 ) 5 NCs, abbreviated as NC1, NC2, NC3, and NC4, respectively. Their interatomic interactions were further evaluated using reduced density gradient (RDG) and quantum theory of atoms in molecules (QTAIM) analyses. Among the studied systems, although NC1 exhibited a less negative adsorption energy compared to the other NCs, it indicated strong surface reactivity. Further, NC1 also showed the highest occupied molecular orbital (HOMO)–lowest unoccupied molecular orbital (LUMO) energy gap of 3.66 eV, suggesting greater charge transfer and reactivity. Additionally, dipole moment, global reactivity descriptors, molecular electrostatic potential (MEP) surface, and natural bond orbital (NBO) results of the NCs were more favorable than those of cisplatin. Based on the DFT results, the protonated NC1, i.e. (TiO 2 ) 2 H 2 was selected for further analysis of its interactions with HEWL. The docking scores of cisplatin, (TiO 2 ) 2 H 2 , and cis-(TiO 2 ) 2 H 2 with HEWL were found to be −4.41, −3.82, and −6.74 kcal mol −1 , respectively, indicating strong binding affinity and therapeutic potential of cis-(TiO 2 ) 2 H 2 . More experimental investigations are required to confirm its effectiveness.
- 1 November 2025
- Published by IOP Publishing in Materials Research Express
- Vol. 12 (11) , 115001
Open AccessIn silico study on structural, electronic, and adsorption properties of cisplatin/(TiO 2 ) n (n = 2–5) nanoclusters and interactions with hen egg white lysozyme
This study explored the structural, adsorption, and electronic properties of titania nanostructures loaded with cisplatin (cis) using density functional theory (DFT) at the level of B3LYP/LANL2DZ functional in gas phase, and examined the binding potential of the cis-(TiO 2 ) n (n = 2–5) nanoclusters (NCs) with hen egg white lysozyme (HEWL) via molecular docking. Our results revealed that cisplatin adsorption on (TiO 2 ) n NCs yielded adsorption energies of −56.97, −53.84, −48.40, and −39.23 kcal mol −1 for cis-(TiO 2 ) 2 , cis-(TiO 2 ) 3 , cis-(TiO 2 ) 4 , and cis-(TiO 2 ) 5 NCs, abbreviated as NC1, NC2, NC3, and NC4, respectively. Their interatomic interactions were further evaluated using reduced density gradient (RDG) and quantum theory of atoms in molecules (QTAIM) analyses. Among the studied systems, although NC1 exhibited a less negative adsorption energy compared to the other NCs, it indicated strong surface reactivity. Further, NC1 also showed the highest occupied molecular orbital (HOMO)–lowest unoccupied molecular orbital (LUMO) energy gap of 3.66 eV, suggesting greater charge transfer and reactivity. Additionally, dipole moment, global reactivity descriptors, molecular electrostatic potential (MEP) surface, and natural bond orbital (NBO) results of the NCs were more favorable than those of cisplatin. Based on the DFT results, the protonated NC1, i.e. (TiO 2 ) 2 H 2 was selected for further analysis of its interactions with HEWL. The docking scores of cisplatin, (TiO 2 ) 2 H 2 , and cis-(TiO 2 ) 2 H 2 with HEWL were found to be −4.41, −3.82, and −6.74 kcal mol −1 , respectively, indicating strong binding affinity and therapeutic potential of cis-(TiO 2 ) 2 H 2 . More experimental investigations are required to confirm its effectiveness.
- 31 October 2025
- Published by Wiley in Advanced Theory and Simulations
- Vol. 9 (2)
An Integrated Molecular Modeling with MPNN, MD Simulations, MM/PBSA, ADMET, and SHAP Analyses to Identify GyrB/PqsR Inhibitors Against Pseudomonas aeruginosa
Antibiotic resistance in Pseudomonas aeruginosa underscores the urgent need for new therapeutics targeting multiple bacterial pathways. In this study, a graph neural network‐driven framework is presented, integrating Message Passing Neural Networks (MPNNs) with atom‐level SHAP interpretability to predict antibacterial activity, complemented by clustering, molecular docking, and molecular dynamics simulations. From 96 structurally diverse candidates, two molecules‐ LIG61 (4‐[5‐(6‐acetyl‐5‐hydroxy‐4‐methyl‐2,8‐dioxo‐9,10‐dihydropyrano[2,3‐h]chromen‐10‐yl)furan‐2‐yl]benzoic acid) and LIG87 ([2‐[(2‐methylphenyl)methylidene]‐3‐oxo‐1‐benzofuran‐6‐yl] N , N ‐diphenylcarbamate)‐demonstrates inhibitory potential against DNA gyrase subunit B (GyrB) and the quorum‐sensing regulator PqsR. Docking reveals that both ligands establish key polar and hydrophobic interactions with experimentally validated residues, consistent with reported co‐crystal data. MD simulations confirm stable interactions of LIG61 and LIG87 with their targets, and subsequent MM/PBSA analysis yielded binding affinities of −9.94 and −16.89 kcal mol −1 for LIG61, and −17.84 and −29.23 kcal mol −1 for LIG87, toward GyrB and PqsR, respectively. Predicted acute toxicity indicates LD 50 values of 400 mg kg −1 for LIG61 and 500 mg kg −1 for LIG87, demonstrating a favorable toxicity profile. SHAP‐based atom‐level interpretation of the MPNN predictions further identified key hydroxyl, lactone, and aromatic moieties underpinning bioactivity. Together, these findings highlight computational framework capable of identifying dual inhibitors with atomistic insights, with the understanding that in vitro and in vivo studies are required for validation.
- 31 October 2025
- Published by Wiley in Advanced Theory and Simulations
- Vol. 9 (2)
An Integrated Molecular Modeling with MPNN, MD Simulations, MM/PBSA, ADMET, and SHAP Analyses to Identify GyrB/PqsR Inhibitors Against Pseudomonas aeruginosa
Antibiotic resistance in Pseudomonas aeruginosa underscores the urgent need for new therapeutics targeting multiple bacterial pathways. In this study, a graph neural network‐driven framework is presented, integrating Message Passing Neural Networks (MPNNs) with atom‐level SHAP interpretability to predict antibacterial activity, complemented by clustering, molecular docking, and molecular dynamics simulations. From 96 structurally diverse candidates, two molecules‐ LIG61 (4‐[5‐(6‐acetyl‐5‐hydroxy‐4‐methyl‐2,8‐dioxo‐9,10‐dihydropyrano[2,3‐h]chromen‐10‐yl)furan‐2‐yl]benzoic acid) and LIG87 ([2‐[(2‐methylphenyl)methylidene]‐3‐oxo‐1‐benzofuran‐6‐yl] N , N ‐diphenylcarbamate)‐demonstrates inhibitory potential against DNA gyrase subunit B (GyrB) and the quorum‐sensing regulator PqsR. Docking reveals that both ligands establish key polar and hydrophobic interactions with experimentally validated residues, consistent with reported co‐crystal data. MD simulations confirm stable interactions of LIG61 and LIG87 with their targets, and subsequent MM/PBSA analysis yielded binding affinities of −9.94 and −16.89 kcal mol −1 for LIG61, and −17.84 and −29.23 kcal mol −1 for LIG87, toward GyrB and PqsR, respectively. Predicted acute toxicity indicates LD 50 values of 400 mg kg −1 for LIG61 and 500 mg kg −1 for LIG87, demonstrating a favorable toxicity profile. SHAP‐based atom‐level interpretation of the MPNN predictions further identified key hydroxyl, lactone, and aromatic moieties underpinning bioactivity. Together, these findings highlight computational framework capable of identifying dual inhibitors with atomistic insights, with the understanding that in vitro and in vivo studies are required for validation.
- Open Access
- 10 July 2025
- Published by College of Graduate Studies, Walailak University in Trends in Sciences
- Vol. 22 (9) , 10384
DFT Analysis on Electronic Properties, Reactivity and Adsorption Mechanism of Favipiravir/XTiO4H2 (X = Pt, Zr, Zn) Nanocomplexes and their Biological Evaluations
The objective of this study is to explore quantum chemical properties of favipiravir- loaded XTiO4H2 nanostructures (X = Pt, Zr, Zn) using density functional theory and to evaluate their toxicity profiling, drug-likeness and binding efficacy to the target proteins. Favipiravir interacted strongly with XTiO4H2 forming the stable nanocomplexes (NCs) having adsorption energy in the range of −2.49 to −4.70 eV in gas phase. The HOMO-LUMO energy gap of favipiravir was 3.56 eV whereas Fav + PtTiO4H2 (NC1), Fav + ZrTiO4H2 (NC2), and Fav + ZnTiO4H2 (NC3) exhibited lower energy gaps of 1.23, 1.43 and 0.65 eV in gas phase, respectively, showing better reactivity of these NCs. The results of dipole moment, global reactivity descriptor, MEP surface, NBO, QTAIM and NCI of the proposed NCs were more favorable than that of favipiravir. The functionalized TiO2 NCs exhibited better docking scores, among which NC2 showed the strongest inhibition of SARS-CoV-2 main protease and spike protein. NC3 having the predicted LD50 of 3,000 mg/kg in toxicity class V appears to be less toxic than favipiravir having LD50 of 1,717 mg/kg in the class IV. This study confirms the possibility of using transition metal-doped titania nanostructures for targeted drug delivery, antiviral therapy and photocatalytic degradation of the drugs. HIGHLIGHTS Favipiravir with XTiO4H2 (X = Pt, Zr, Zn) nanocomplexes exhibited significant adsorption energies ranging from -1.18 to -4.70 eV. The HOMO-LUMO energy gaps of the nanocomplexes (0.65-1.23 eV) were lower than that of favipiravir (3.56 eV), enhancing electronic reactivity. Quantum chemical parameters like dipole moment, global reactivity descriptors, MEP surface, NBO, QTAIM and NCI analyzed the physicochemical properties of the proposed nanocomplexes. Fav+ZrTiO4H2 showed the strongest binding score with SARS-CoV-2 main protease and spike protein, while Fav+ZnTiO4H2 exhibited the least toxicity (LD50 = 3000 mg/kg, class V) GRAPHICAL ABSTRACT
- 10 July 2025
- Published by College of Graduate Studies, Walailak University in Trends in Sciences
- Vol. 22 (9) , 10384
Open AccessDFT Analysis on Electronic Properties, Reactivity and Adsorption Mechanism of Favipiravir/XTiO4H2 (X = Pt, Zr, Zn) Nanocomplexes and their Biological Evaluations
The objective of this study is to explore quantum chemical properties of favipiravir- loaded XTiO4H2 nanostructures (X = Pt, Zr, Zn) using density functional theory and to evaluate their toxicity profiling, drug-likeness and binding efficacy to the target proteins. Favipiravir interacted strongly with XTiO4H2 forming the stable nanocomplexes (NCs) having adsorption energy in the range of −2.49 to −4.70 eV in gas phase. The HOMO-LUMO energy gap of favipiravir was 3.56 eV whereas Fav + PtTiO4H2 (NC1), Fav + ZrTiO4H2 (NC2), and Fav + ZnTiO4H2 (NC3) exhibited lower energy gaps of 1.23, 1.43 and 0.65 eV in gas phase, respectively, showing better reactivity of these NCs. The results of dipole moment, global reactivity descriptor, MEP surface, NBO, QTAIM and NCI of the proposed NCs were more favorable than that of favipiravir. The functionalized TiO2 NCs exhibited better docking scores, among which NC2 showed the strongest inhibition of SARS-CoV-2 main protease and spike protein. NC3 having the predicted LD50 of 3,000 mg/kg in toxicity class V appears to be less toxic than favipiravir having LD50 of 1,717 mg/kg in the class IV. This study confirms the possibility of using transition metal-doped titania nanostructures for targeted drug delivery, antiviral therapy and photocatalytic degradation of the drugs. HIGHLIGHTS Favipiravir with XTiO4H2 (X = Pt, Zr, Zn) nanocomplexes exhibited significant adsorption energies ranging from -1.18 to -4.70 eV. The HOMO-LUMO energy gaps of the nanocomplexes (0.65-1.23 eV) were lower than that of favipiravir (3.56 eV), enhancing electronic reactivity. Quantum chemical parameters like dipole moment, global reactivity descriptors, MEP surface, NBO, QTAIM and NCI analyzed the physicochemical properties of the proposed nanocomplexes. Fav+ZrTiO4H2 showed the strongest binding score with SARS-CoV-2 main protease and spike protein, while Fav+ZnTiO4H2 exhibited the least toxicity (LD50 = 3000 mg/kg, class V) GRAPHICAL ABSTRACT
- 9 March 2025
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 39 (4)
Synthesis, Characterization, and Antimicrobial Activity of Hydrazino Triazole–Based Schiff Base Ligands and Their Oxovanadium (IV) Complexes and the Inhibitory Roles Against SARS‐CoV‐2 Using Molecular Docking, Dynamics, and ADMET Profiling
This study addresses the structural analysis and bioactivity evaluation of newly synthesized hydrazino triazole‐based Schiff base ligands (SS and SA) and their oxovanadium (IV) complexes (DS and DA). The synthesized ligands and complexes were characterized using Fourier transform infrared (FTIR) spectroscopy, X‐ray diffraction (XRD) patterns, and ultraviolet–visible (UV–Vis) spectroscopy. The XRD patterns of the complexes indicate the presence of tiny polycrystalline phases, with a crystallite size of 17.538 nm for DS. Biological activity was assessed in vitro against bacterial pathogens Klebsiella pneumoniae, Escherichia coli, Staphylococcus aureus, Bacillus subtilis, and the fungal species Candida albicans. Complex DA demonstrated prominent antimicrobial activity with a ZOI value of 12, 9, 8, 7, and 7 mm, respectively, against the tested bacterial and fungal species, and the complex DS has promising antioxidant activity with an IC50 value of 46.23 μg/mL. Alpha‐amylase inhibitory effects were relatively low for SA and SS, with a mean inhibitory percent value of 7.33% and 8.29%, while DA and DS demonstrated the highest inhibitions of 16.18% and 11.27%, respectively, highlighting their limited potential as alpha‐amylase inhibitors. The docking scores of triazole, hydrazino triazole, and Schiff base ligands (SA and SS) with SARS‐CoV‐2 Mpro were −5.91, −6.27, −11.47, and −10.15 kcal/mol, respectively, with SA exhibiting the better binding affinity, suggesting its prominent activity. Molecular dynamic (MD) simulations over 100 ns, assessing parameters such as RMSD, RMSF, Rg, SASA, and H‐bonds, revealed that SS maintained greater stability than the other ligands. The end‐point energy (MM/PBSA) of the Schiff base ligand SS with Mpro was calculated as −18.25 kcal/mol. The ADMET parameters, docking scores, and MD simulation results suggested SS as a potential drug candidate against COVID‐19. This study highlights the multitarget activity of Schiff bases and their compounds, emphasizing the importance of future research on related compounds to unlock their full therapeutic potential across diverse medical applications.
- 9 March 2025
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 39 (4)
Synthesis, Characterization, and Antimicrobial Activity of Hydrazino Triazole–Based Schiff Base Ligands and Their Oxovanadium (IV) Complexes and the Inhibitory Roles Against SARS‐CoV‐2 Using Molecular Docking, Dynamics, and ADMET Profiling
This study addresses the structural analysis and bioactivity evaluation of newly synthesized hydrazino triazole‐based Schiff base ligands (SS and SA) and their oxovanadium (IV) complexes (DS and DA). The synthesized ligands and complexes were characterized using Fourier transform infrared (FTIR) spectroscopy, X‐ray diffraction (XRD) patterns, and ultraviolet–visible (UV–Vis) spectroscopy. The XRD patterns of the complexes indicate the presence of tiny polycrystalline phases, with a crystallite size of 17.538 nm for DS. Biological activity was assessed in vitro against bacterial pathogens Klebsiella pneumoniae, Escherichia coli, Staphylococcus aureus, Bacillus subtilis, and the fungal species Candida albicans. Complex DA demonstrated prominent antimicrobial activity with a ZOI value of 12, 9, 8, 7, and 7 mm, respectively, against the tested bacterial and fungal species, and the complex DS has promising antioxidant activity with an IC50 value of 46.23 μg/mL. Alpha‐amylase inhibitory effects were relatively low for SA and SS, with a mean inhibitory percent value of 7.33% and 8.29%, while DA and DS demonstrated the highest inhibitions of 16.18% and 11.27%, respectively, highlighting their limited potential as alpha‐amylase inhibitors. The docking scores of triazole, hydrazino triazole, and Schiff base ligands (SA and SS) with SARS‐CoV‐2 Mpro were −5.91, −6.27, −11.47, and −10.15 kcal/mol, respectively, with SA exhibiting the better binding affinity, suggesting its prominent activity. Molecular dynamic (MD) simulations over 100 ns, assessing parameters such as RMSD, RMSF, Rg, SASA, and H‐bonds, revealed that SS maintained greater stability than the other ligands. The end‐point energy (MM/PBSA) of the Schiff base ligand SS with Mpro was calculated as −18.25 kcal/mol. The ADMET parameters, docking scores, and MD simulation results suggested SS as a potential drug candidate against COVID‐19. This study highlights the multitarget activity of Schiff bases and their compounds, emphasizing the importance of future research on related compounds to unlock their full therapeutic potential across diverse medical applications.